Head-to-head dispatch
Peter MD vs Strut Health
Two GLP-1 providers, one scorecard. Both are graded on the same six Desk Score dimensions — here is how they stack up, and which one fits you.
Desk Score
A physician-prescribed telehealth brand pairing GLP-1 tirzepatide and compounded semaglutide+B12 with TRT, sermorelin, NAD+, hair-loss and ED care on one account — tirzepatide from $249/mo, semaglutide+B12 from $149/mo.
Desk Score
The same molecule as a lozenge or an injection at the same price — the only place on this board where the needle is genuinely optional.
Strut Health takes this head-to-head with the higher Desk Score, 88/100 (B+) against 80/100 (B−) for Peter MD. Peter MD still holds its ground where its strengths line up with yours.
Desk Score, dimension by dimension
Same six measured dimensions for both. The red flag marks the stronger side. See the methodology.
Peter MD
80/100
B−
Strut Health
88/100
B+
Price transparency
State access
Molecule range
Onboarding speed
Support responsiveness
Licensing & trust
The spec sheet
| Field | Peter MD | Strut Health |
|---|---|---|
| Semaglutide | $149/mo (GLP1+B12, compounded, first-time tier; $139/mo returning-patient tier) | From $99/mo sublingual, $149/mo injectable |
| Tirzepatide | $249/mo (60mg, billed quarterly; $149 first month) | From $199/mo either route |
| Coverage | Most states (restrictions vary by treatment — excludes several, incl. AL, ID) | 49 states (not Arkansas) |
| Brand-name | Compounded only | Compounded only |
| Oral option | Injectable only | Yes |
| Best for | Patients who want GLP-1 care alongside TRT, NAD+, sermorelin or other men's-health treatments under one physician-guided account, and don't need brand-name or oral routes. | People whose real objection is the needle rather than the medicine, and who want every route priced before signing up. |
| Desk Score | 80/100B− | 88/100B+ |
The verdict
Desk pick — Strut HealthStrut Health takes this head-to-head with the higher Desk Score, 88/100 (B+) against 80/100 (B−) for Peter MD. Peter MD still holds its ground where its strengths line up with yours.
Choose Peter MD if…
Patients who want GLP-1 care alongside TRT, NAD+, sermorelin or other men's-health treatments under one physician-guided account, and don't need brand-name or oral routes.
$149/mo (GLP1+B12, compounded, first-time tier; $139/mo returning-patient tier) sema · $249/mo (60mg, billed quarterly; $149 first month) tirz · Most states (restrictions vary by treatment — excludes several, incl. AL, ID)
Choose Strut Health if…
People whose real objection is the needle rather than the medicine, and who want every route priced before signing up.
From $99/mo sublingual, $149/mo injectable sema · From $199/mo either route tirz · 49 states (not Arkansas)
Assume any provider we list may compensate us — we may earn a referral commission at no extra cost to you, and what we file on a provider reads the same either way. Read full breakdowns: Peter MD · Strut Health.
Also on the board
CoreAge Rx tops every dispatch at 94/100
Whichever of these two you lean toward, the Desk's #1-rated provider outscores them both. The Desk's top dispatch: flat all-in pricing, both molecules, all 50 states — no teaser-rate traps.
More head-to-heads
- Peter MD vs CoreAge Rx
- Strut Health vs Vaylen
- Peter MD vs Ondra Health
- Strut Health vs Invigor Medical
- Peter MD vs Vytora Health
- Strut Health vs Sesame Care
Or see the full comparison hub and the complete board.
Pricing and verification reflect each provider's public disclosures at last scoring; the Desk Score is our editorial judgment per the methodology. Prices change — confirm on each provider's own site. Not medical advice; see our disclosure.